Elder Vicente Quispe-Huamani
Elder Vicente Quispe-Huamani has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Hector Luis Bojorquez-Castillo
Hospital Nacional Edgardo Rebagliati Martins: Lima, Lima, PE, Peru
2 shared publications - Claudia Cecilia Quispe-Vasquez1 shared publication
- Fiorella Navarro-Vásquez
Hospital Nacional Dos de Mayo, Peru
1 shared publication - Germán Salazar Aldea
Pathology Department, Edgardo Rebagliati Martins National Hospital, EsSalud, Av. Edgardo Rebagliati 490, Jesús María, Lima 15072
1 shared publication - Gustavo Lorenzo Moretta
Universidad San Martín de Porres, Peru
1 shared publication - Heidi Vela
Independent Researcher, Peru
1 shared publication
Latest Publications
- Open Access
- 29 April 2026
- Published by MDPI AG in Preprints.org
Clinical, Genetic and Phenotypic Characterization of Hereditary Transthyretin Amyloidosis (ATTRv) in Peruvian Population: Real-World Data from a Case Series — IMPAC-FE Study
Background: Hereditary transthyretin amyloidosis (ATTRv) is a rare multisystemic disease with variable phenotypic expression. No published data exist on the clinical characteristics of ATTRv in Peruvian population.Objective: To describe the demographic, genetic, and clinical characteristics of patients with ATTRv in Peru, and to determine the distribution of clinical phenotypes according to internationally validated criteria.Methods: Descriptive, observational, retrospective case series of patients with ATTRv confirmed by molecular genetic testing, evaluated in Lima, Peru, between 2021 and December 2025 (IMPAC-FE study). Demographic, genetic, neurological (NIS, Norfolk QOL-DN, PND), autonomic (COMPASS-31, SUDOSCAN), and cardiovascular variables (echocardiography, septal thickness, E/e', apical sparing pattern, Tc99m-pyrophosphate scintigraphy, NT-proBNP, troponin) were evaluated. Phenotypes were classified according to AHA/ACC criteria and the THAOS registry.Results: Twenty-three patients were included (69.6% male, median age 60 years, IQR 45-70). The variants were Val142Ile (56.5%), Ala65Val (34.8%), and Val50Met (8.7%). Overall phenotype distribution: preclinical 34.8%, mixed 39.1%, cardiac 21.7%, neurological 4.3%. Norfolk QOL-DN (n=18): median 6.0. COMPASS-31 (n=18): median 6.0. LVEF (n=16): mean 60.5%. LV Mass (n=12): mean 102.9g. Troponin T (n=9): median 47 ng/L. PYP Scintigraphy (n=9): Perugini 3 in 77.8%.Conclusions: This first case series of ATTRv in Peruvian population shows clinical and genetic heterogeneity, with predominance of Val142Ile and Ala65Val variants, and a phenotypic distribution compatible with international registries. The high proportion of preclinical patients and extended cardiovascular evaluation reinforce the need for early diagnosis and timely initiation of disease-modifying therapies.
- 29 April 2026
- Published by MDPI AG in Preprints.org
Open AccessClinical, Genetic and Phenotypic Characterization of Hereditary Transthyretin Amyloidosis (ATTRv) in Peruvian Population: Real-World Data from a Case Series — IMPAC-FE Study
Background: Hereditary transthyretin amyloidosis (ATTRv) is a rare multisystemic disease with variable phenotypic expression. No published data exist on the clinical characteristics of ATTRv in Peruvian population.Objective: To describe the demographic, genetic, and clinical characteristics of patients with ATTRv in Peru, and to determine the distribution of clinical phenotypes according to internationally validated criteria.Methods: Descriptive, observational, retrospective case series of patients with ATTRv confirmed by molecular genetic testing, evaluated in Lima, Peru, between 2021 and December 2025 (IMPAC-FE study). Demographic, genetic, neurological (NIS, Norfolk QOL-DN, PND), autonomic (COMPASS-31, SUDOSCAN), and cardiovascular variables (echocardiography, septal thickness, E/e', apical sparing pattern, Tc99m-pyrophosphate scintigraphy, NT-proBNP, troponin) were evaluated. Phenotypes were classified according to AHA/ACC criteria and the THAOS registry.Results: Twenty-three patients were included (69.6% male, median age 60 years, IQR 45-70). The variants were Val142Ile (56.5%), Ala65Val (34.8%), and Val50Met (8.7%). Overall phenotype distribution: preclinical 34.8%, mixed 39.1%, cardiac 21.7%, neurological 4.3%. Norfolk QOL-DN (n=18): median 6.0. COMPASS-31 (n=18): median 6.0. LVEF (n=16): mean 60.5%. LV Mass (n=12): mean 102.9g. Troponin T (n=9): median 47 ng/L. PYP Scintigraphy (n=9): Perugini 3 in 77.8%.Conclusions: This first case series of ATTRv in Peruvian population shows clinical and genetic heterogeneity, with predominance of Val142Ile and Ala65Val variants, and a phenotypic distribution compatible with international registries. The high proportion of preclinical patients and extended cardiovascular evaluation reinforce the need for early diagnosis and timely initiation of disease-modifying therapies.
- 19 September 2025
- Published by Sociedad Peruana de Medicina Interna in Revista de la Sociedad Peruana de Medicina Interna
- Vol. 38 (3) , 244-248
Fiebre de origen desconocido con compromiso neurológico como manifestación inicial: un caso de vasculitis sistémica
Paciente mujer de 74 años con antecedentes de artritis reumatoide y fibrosis pulmonar presenta 4 semanas de fiebre, paresias a nivel de ambos miembros inferiores e hiporreflexia rotuliana y aquiliana asociada a exámenes laboratoriales con evidencia de proteinuria significativa sin rango nefrótico, anticuerpo anticitoplasma de neutrófilos (ANCA) MPO (+) y una electromiografía con evidencia de polineuropatía sensitiva-motora crónica de tipo axonal con denervación activa, lo cual justificó el razonamiento clínico hacia un cuadro de Vasculitis de vasos pequeños. En ausencia de glomerulonefritis rápidamente progresiva, se vio pertinente la realización de una biopsia de nervio sural con inmunohistoquímica confirmatoria con un cuadro compatible con Poliangeitis microscópica (PAM). La PAM, al ser una entidad que suele debutar con compromiso renal marcado, torna el diagnóstico difícil ante la ausencia de este, lo cual hace pertinente la revisión del caso.
- 19 September 2025
- Published by Sociedad Peruana de Medicina Interna in Revista de la Sociedad Peruana de Medicina Interna
- Vol. 38 (3) , 244-248
Fiebre de origen desconocido con compromiso neurológico como manifestación inicial: un caso de vasculitis sistémica
Paciente mujer de 74 años con antecedentes de artritis reumatoide y fibrosis pulmonar presenta 4 semanas de fiebre, paresias a nivel de ambos miembros inferiores e hiporreflexia rotuliana y aquiliana asociada a exámenes laboratoriales con evidencia de proteinuria significativa sin rango nefrótico, anticuerpo anticitoplasma de neutrófilos (ANCA) MPO (+) y una electromiografía con evidencia de polineuropatía sensitiva-motora crónica de tipo axonal con denervación activa, lo cual justificó el razonamiento clínico hacia un cuadro de Vasculitis de vasos pequeños. En ausencia de glomerulonefritis rápidamente progresiva, se vio pertinente la realización de una biopsia de nervio sural con inmunohistoquímica confirmatoria con un cuadro compatible con Poliangeitis microscópica (PAM). La PAM, al ser una entidad que suele debutar con compromiso renal marcado, torna el diagnóstico difícil ante la ausencia de este, lo cual hace pertinente la revisión del caso.
- Open Access
- 7 October 2024
- Published by Cuerpo Médico del Hospital Nacional Edgardo Rebagliati Martins in Revista Médica Rebagliati
- Vol. 4 (2) , 72-6
Importancia de la resonancia magnética muscularen el abordaje diagnóstico de patologíasmusculares, a propósito de un caso
Muscle magnetic resonance imaging is a non-invasive method which is gaining importance in the field of neuromuscular pathologies. With this study it is possible to describe patterns of muscle involvement, request genetic studies or select a biopsy site, but it is also used in the assessment of the progression of the disease and is especially useful in case of variants ofuncertain significance as it supports their interpretation. In our center, as in many nationwide, there is no availability of first-hand genetic studies, so the use of available diagnostic methods is of vital importance for final diagnoses. We present the case of a patient with chronic manifestations and no clear diagnosis in whom the magnetic resonance study made it possible to guide the appropriate genetic study to confirm his diagnosis.
- 7 October 2024
- Published by Cuerpo Médico del Hospital Nacional Edgardo Rebagliati Martins in Revista Médica Rebagliati
- Vol. 4 (2) , 72-6
Open AccessImportancia de la resonancia magnética muscularen el abordaje diagnóstico de patologíasmusculares, a propósito de un caso
Muscle magnetic resonance imaging is a non-invasive method which is gaining importance in the field of neuromuscular pathologies. With this study it is possible to describe patterns of muscle involvement, request genetic studies or select a biopsy site, but it is also used in the assessment of the progression of the disease and is especially useful in case of variants ofuncertain significance as it supports their interpretation. In our center, as in many nationwide, there is no availability of first-hand genetic studies, so the use of available diagnostic methods is of vital importance for final diagnoses. We present the case of a patient with chronic manifestations and no clear diagnosis in whom the magnetic resonance study made it possible to guide the appropriate genetic study to confirm his diagnosis.